Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: A pilot randomised controlled trial

BMC Gastroenterology

Volumn 15, Issue 1, 2015, Pages

  Mikocka Walus, Antonina ^a,b,c   Bampton, Peter ^d,e   Hetzel, David ^f   Hughes, Patrick ^g   Esterman, Adrian ^a   Andrews, Jane M ^c,d,f  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

^e FLINDERS MEDICAL CENTRE   (Australia)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cognitive behavioural therapy; Flare; Mental health; Psychological; Quality of life; Remission

Indexed keywords

ADULT; ANXIETY; ARTICLE; BLOOD ANALYSIS; COGNITIVE THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL HEALTH; MIDDLE AGED; OUTCOME ASSESSMENT; PILOT STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; THERAPY EFFECT; TOTAL QUALITY MANAGEMENT; TREATMENT RESPONSE; COMPARATIVE STUDY; INFLAMMATORY BOWEL DISEASES; MULTIMODALITY CANCER THERAPY; PSYCHOLOGY; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HEALTH STATUS; HUMANS; INFLAMMATORY BOWEL DISEASES; LINEAR MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84929167642     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-015-0278-2     Document Type: Article

References (45)

1. Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008;118(6):2209-18.
2. Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2011;105(9):1994-2002.
3. Camara RJ, Ziegler R, Begre S, Schoepfer AM, von Kanel R, Swiss Inflammatory Bowel Disease Cohort Study group. The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research. Digestion. 2009;80(2):129-39.
4. Maunder RG, Levenstein S. The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. Curr Mol Med. 2008;8(4):247-52.
5. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009;15(7):1105-18.
6. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009;58(3):367-78.
7. von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis. 2006;12(12):1175-84.
8. Timmer A, Preiss JC, Motschall E, Rucker G, Jantschek G, Moser G. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2011;2:CD006913.
9. Knowles SR, Monshat K, Castle DJ. The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis. 2013;19(12):2704-15.
10. McCombie AM, Mulder RT, Gearry RB. Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis. 2013;7(12):935-49.
11. Lichtenstein GR, Hanauer SB, Kane SV, Present DH. Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease. Inflamm Bowel Dis. 2004;10 Suppl 2:S2-10.
12. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004;66(1):79-84.
13. Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69(4):621-32.
14. Pragmatic trials [ http://www.consort-statement.org/extensions/designs/pragmatic-trials/ ]
15. Mikocka-Walus AA, Gordon AL, Stewart BJ, Andrews JM. The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit. J Psychosom Res. 2012;72(2):165-7.
16. Better access to mental health care: fact sheet for patients [ http://www.health.gov.au/internet/main/publishing.nsf/content/mental-ba-fact-pat ]
17. Bee PE, Bower P, Lovell K, Gilbody S, Richards D, Gask L, et al. Psychotherapy mediated by remote communication technologies: a meta-analytic review. BMC Psychiatry. 2008;8:60.
18. Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, et al. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess. 2006;10(33):iii. xi-xiv, 1-168.
19. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(2):590-8.
20. Bai A, Ma AG, Yong M, Weiss CR, Ma Y, Guan Q, et al. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. Biochem Pharmacol. 2010;80(11):1708-17.
21. Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D'Haens G, et al. IBD around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the world digestive health Day 2010 - inflammatory bowel disease task force meeting. Inflamm Bowel Dis. 2011;17(2):639-44.
22. Singh H, Penfold RB, De Coster C, Au W, Bernstein CN, Moffatt M. Predictors of serious complications associated with lower gastrointestinal endoscopy in a major city-wide health region. Can J Gastroenterol. 2010;24(7):425-30.
23. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology. 2010;139(4):1128-37.
24. Bernstein CN. Anti-tumor necrosis factor therapy in Crohn's disease: more information and more questions about the long term. Clin Gastroenterol Hepatol. 2010;8(7):556-8.
25. Best WR, Becktel JM, Singleton JW, Kern Jr F. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology. 1976;70(3):439-44.
26. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43(1):29-32.
27. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306(6890):1437-40.
28. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83.
29. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
30. Spielberger CD. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
31. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100.
32. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res. 1967;11(2):213-8.
33. Carr JL, Moffett JA, Sharp DM, Haines DR. Is the Pain Stages of Change Questionnaire (PSOCQ) a useful tool for predicting participation in a self-management programme? Further evidence of validity, on a sample of UK pain clinic patients. BMC Musculoskelet Disord. 2006;7:101.
34. Duncan A, Wilson C, Cole SR, Mikocka-Walus A, Turnbull D, Young GP. Demographic associations with stage of readiness to screen for colorectal cancer. Health Promot J Austr. 2009;20(1):7-12.
35. Prochaska JO, DiClemente CC. The transtheoretical approach: towards a systematic eclectic framework. Homewood, IL: Dow Jones Irwin; 1984.
36. Diaz Sibaja MA, Comeche Moreno MI, Mas Hesse B. Protocolized cognitive-behavioural group therapy for inflammatory bowel disease. Rev Esp Enferm Dig. 2007;99(10):593-8.
37. Mussell M, Bocker U, Nagel N, Olbrich R, Singer MV. Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness. Scand J Gastroenterol. 2003;38(7):755-62.
38. Schwarz SP, Blanchard EB. Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther. 1991;29(2):167-77.
39. Szigethy E, Carpenter J, Baum E, Kenney E, Baptista-Neto L, Beardslee WR, et al. Case study: longitudinal treatment of adolescents with depression and inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2006;45(4):396-400.
40. Szigethy E, Kenney E, Carpenter J, Hardy DM, Fairclough D, Bousvaros A, et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1290-8.
41. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17-31.
42. Keller W, Pritsch M, Von Wietersheim J, Scheib P, Osborn W, Balck F, et al. Effect of psychotherapy and relaxation on the psychosocial and somatic course of Crohn's disease: main results of the German Prospective Multicenter Psychotherapy Treatment study on Crohn's Disease. J Psychosom Res. 2004;56(6):687-96.
43. Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013;38(7):761-71.
44. Miehsler W, Weichselberger M, Offerlbauer-Ernst A, Dejaco C, Reinisch W, Vogelsang H, et al. Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis. 2008;14(9):1273-80.
45. Waller R, Gilbody S. Barriers to the uptake of computerized cognitive behavioural therapy: a. Psychol Med. 2009;39(5):705-12.